NanoViricides, Inc. (NNVC) News
Track canonical SquawkNews coverage tagged to NNVC, NanoViricides, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
NNVC NanoViricides prices offering with 2,516,339 warrants at US$ 1.75 exercise price
NNVC NanoViricides prices offering with 2,516,339 warrants at US$ 1.75 exercise price
EQUITY | Jul 24, 2026, 12:10 PM UTC
L
NNVC nanoviricides, Inc: sufficient quantity of NV-387 oral gummies drug product for starting clinical trial against ebola is already availa
NNVC nanoviricides, Inc: sufficient quantity of NV-387 oral gummies drug product for starting clinical trial against ebola is already available in drc
EQUITY | Jul 22, 2026, 12:33 PM UTC
L
NanoViricides initiated with bullish view at Noble Capital, here's why
Noble Capital initiated...
EQUITY | Jul 06, 2026, 01:30 PM UTC
L
NanoViricides Continues To Advance Broad-Spectrum Antiviral Drug NV-387 Towards Phase II Clinical Trial Of NV-387 Oral Gummies Formulation A
NanoViricides, Inc. (NYSE: NNVC ) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, updates that it has continued to advance its broad-spectrum antiviral drug NV-387 towards
EQUITY | Jul 06, 2026, 12:40 PM UTC
M
FDA's Office Of Orphan Products Development Grants Rare Pediatric Disease Drug Designation To NanoViricides' Antiviral Drug NV-387
NanoViricides, Inc., a publicly traded company (NYSE American: NNVC ) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine techn
REGULATION | Jun 29, 2026, 12:40 PM UTC
M
NNVC Ships Monkeypox Treatment
NanoViricides ships NV-387 oral gummies to the Democratic Republic of Congo for its Phase II clinical trial of monkeypox treatment
EQUITY | Jun 22, 2026, 01:35 PM UTC